<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Healthcare on FinanClub</title>
    <link>https://finan.club/tags/healthcare/</link>
    <description>Recent content in Healthcare on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 11 Sep 2023 06:23:48 +0000</lastBuildDate><atom:link href="https://finan.club/tags/healthcare/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>CVS</title>
      <link>https://finan.club/us/cvs/</link>
      <pubDate>Mon, 11 Sep 2023 06:23:48 +0000</pubDate>
      
      <guid>https://finan.club/us/cvs/</guid>
      <description>score:-31
Chances: CVS Health announces additional responsibilities for executive leadership team members, indicating strategic expansion. CVS Health survey finds that more than two-thirds of Americans plan to get a flu shot this season, which can boost revenue. CVS Health launches Cordavis to target the biosimilar market, tapping into a potentially lucrative sector.</description>
    </item>
    
    <item>
      <title>HBAN</title>
      <link>https://finan.club/us/hban/</link>
      <pubDate>Mon, 11 Sep 2023 04:46:03 +0000</pubDate>
      
      <guid>https://finan.club/us/hban/</guid>
      <description>score:40
Chances: Huntington Bancshares is paying out a dividend of $0.155, which may attract income-focused investors. The bank&amp;rsquo;s focus on transforming medical billing with software could lead to revenue growth in the healthcare industry. Huntington National Bank ranks No. 1 among regional banks in the J.</description>
    </item>
    
    <item>
      <title>PFE</title>
      <link>https://finan.club/us/pfe/</link>
      <pubDate>Mon, 11 Sep 2023 04:42:53 +0000</pubDate>
      
      <guid>https://finan.club/us/pfe/</guid>
      <description>score:-8
Chances: Pfizer Inc. (PFE) is a trending stock, indicating strong market interest. Pfizer&amp;rsquo;s COVID-era growth may influence investment decisions. Pfizer and BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID-19 vaccine in the European Union, indicating potential market expansion. Risks: Big Pharma&amp;rsquo;s battle with the Biden administration could have long-lasting consequences, posing regulatory risks.</description>
    </item>
    
    <item>
      <title>PLTR</title>
      <link>https://finan.club/us/pltr/</link>
      <pubDate>Mon, 11 Sep 2023 04:33:07 +0000</pubDate>
      
      <guid>https://finan.club/us/pltr/</guid>
      <description>score:58
Chances: Palantir is partnering with Policlinico Gemelli to use AI for healthcare data science, potentially opening new revenue streams. Palantir customers are showcasing the company&amp;rsquo;s AI platform at AIPCon, indicating strong adoption and potential growth. Cathie Wood recently purchased Palantir stock, suggesting confidence in its long-term prospects.</description>
    </item>
    
    <item>
      <title>KVUE</title>
      <link>https://finan.club/us/kvue/</link>
      <pubDate>Mon, 11 Sep 2023 04:28:38 +0000</pubDate>
      
      <guid>https://finan.club/us/kvue/</guid>
      <description>score:-17
Chances: Kenvue becomes a fully independent company following the separation from Johnson &amp;amp; Johnson, which could lead to growth opportunities. Kenvue is set to join the S&amp;amp;P 500, indicating positive recognition in the market. Strong second-quarter 2023 results and a positive annual profit forecast may boost investor confidence.</description>
    </item>
    
    <item>
      <title>GH</title>
      <link>https://finan.club/us/gh/</link>
      <pubDate>Sat, 02 Sep 2023 03:08:44 +0000</pubDate>
      
      <guid>https://finan.club/us/gh/</guid>
      <description>score:298
Chances: Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference Guardant Health Stock Sees Renewed Technical Strength Guardant Health (GH) Reports Solid Q2 Results Guardant Health Receives Regulatory Approval from Singapore&amp;rsquo;s Health Sciences Authority for Guardant360® CDx blood test Guardant Health Secures Coverage From Major US Commercial Health Insurers for Guardant360® Blood Test for Comprehensive Genomic Profiling Risks: Further weakness as Guardant Health (NASDAQ:GH) drops 3.</description>
    </item>
    
    <item>
      <title> NVST</title>
      <link>https://finan.club/us/nvst/</link>
      <pubDate>Tue, 08 Aug 2023 07:00:38 +0000</pubDate>
      
      <guid>https://finan.club/us/nvst/</guid>
      <description>score:1237
Chances: Envista announces successful pricing of $435 million Convertible Senior Notes offering. Consistent growth in Specialty Products &amp;amp; Technologies and Equipment &amp;amp; Consumables segments drive Q2 revenues. Envista delivers positive Q2 2023 earnings and revenue surprises. Envista Smile Project completes mission trip to the Dominican Republic, providing dental care to underserved patients.</description>
    </item>
    
  </channel>
</rss>
